FAQ | Contact Us | Home
  DJA Global Pharma  
 
 
DJA Global
                                                  Pharma
 
 
 
   DJA News:
 

Please check our News page for the most recent events.

 
 
 

 
 
 
 
 

FREQUENTLY ASKED QUESTIONS

Q. Who is required to submit an IND?
A.  The IND is a requirement for all persons and firms seeking to ship unapproved  drugs across state lines for use in clinical investigations.  However, the FDA does offer exemptions from IND submission requirements for certain types of clinical testing on products.

Q. Is the new EU Clinical Trial Directive now in effect?
A.  The New EU Clinical Trial Directive became effective as of May, 2004.

Q. Throughout the NDA Review Process, as sponsor, can I request meetings with the reviewing team?
A. Depending on the drug, the sponsor may be eligible throughout the NDA review process to request various meetings with the reviewing team.  Optionally, these meetings can be conducted by videoconference, teleconference, or face-to-face.

Q. How do I keep abreast of current trends in regulatory affairs in the European Union?
A. To keep abreast of the current RA trends in the EU, log on to the following website:

Q. How do I keep abreast of current trends in US or other country regulatory information?
A.  To keep abreast of the current RA trends in the US and other countries, click on useful links on this website and it will take you directly to the websites for US FDA and other countries in Europe, Asia/Oceania, Americas, Africa, and the Middle East.  Other useful links for regulatory information such as RAPS, DIA, WHO & ICH are also provided.

Q. How can I obtain translation of regulatory information?
A. Translation of regulatory and other information obtained from this website is available. This can be obtained by clicking on the appropriate language from the pulldown menu on the bottom of each page.

 
 
DJA Global Pharma
DJA Global Pharma
DJA Global Pharma
DJA Global Pharma
DJA Global Pharma
DJA Global Pharma
 

"DJA provides solutions to your challenges in product development and global regulatory affairs..."

 








DJA
                                          Global Pharma
 
 
Copyright © 2009. DJA Global Pharma. All Rights Reserved.  Terms & Conditions  |  Privacy Policy  |  Contact Us  | Website